The Impact of the 2023 FIGO Staging Update of Endometrial Carcinoma on the Content of Pathological Diagnosis
SI Jing-wen
YU Xiu-jie
SHEN Yan
Abstract：Endometrial carcinoma is the most common malignancy of the female reproductive system.Recent years have witnessed pivotal developments in the diagnosis and treatment,including the quantitative assessment of lymphovascular space invasion,the ultrastaging of sentinel lymph nodes,and the molecular stratification of endometrial carcinoma,all progressively integrated into clinical practice.These new insights have been incorporated into the 2023 version of the staging system by the International Federation of Gynecology and Obstetrics(FIGO),heralding a new era of clinical adoption.The importance of precise pathological evaluation cannot be overstated,serving as a linchpin for prognosticating patient outcomes and steering the course of adjuvant therapies.Through the lens of the updated 2023 FIGO staging for endometrial carcinoma,this discourse aims to elevate the paradigm of pathological diagnosis,promoting a benchmark of standardization and precision for pathologists,thereby empowering clinicians with a deeper and more accurate application of the staging system.
Keywords：Endometrial neoplasmsNeoplasm invasivenessLymphatic metastasisSentinel lymph nodeMolecular typingInternational Federation of Gynecology and Obstetrics
Publication Date：2024-06-15
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：6( 241-246 )